Literature DB >> 16943424

Differential roles of ATM- and Chk2-mediated phosphorylations of Hdmx in response to DNA damage.

Yaron Pereg1, Suzanne Lam, Amina Teunisse, Sharon Biton, Erik Meulmeester, Leonid Mittelman, Giacomo Buscemi, Koji Okamoto, Yoichi Taya, Yosef Shiloh, Aart G Jochemsen.   

Abstract

The p53 tumor suppressor plays a major role in maintaining genomic stability. Its activation and stabilization in response to double strand breaks (DSBs) in DNA are regulated primarily by the ATM protein kinase. ATM mediates several posttranslational modifications on p53 itself, as well as phosphorylation of p53's essential inhibitors, Hdm2 and Hdmx. Recently we showed that ATM- and Hdm2-dependent ubiquitination and subsequent degradation of Hdmx following DSB induction are mediated by phosphorylation of Hdmx on S403, S367, and S342, with S403 being targeted directly by ATM. Here we show that S367 phosphorylation is mediated by the Chk2 protein kinase, a downstream kinase of ATM. This phosphorylation, which is important for subsequent Hdmx ubiquitination and degradation, creates a binding site for 14-3-3 proteins which controls nuclear accumulation of Hdmx following DSBs. Phosphorylation of S342 also contributed to optimal 14-3-3 interaction and nuclear accumulation of Hdmx, but phosphorylation of S403 did not. Our data indicate that binding of a 14-3-3 dimer and subsequent nuclear accumulation are essential steps toward degradation of p53's inhibitor, Hdmx, in response to DNA damage. These results demonstrate a sophisticated control by ATM of a target protein, Hdmx, which itself is one of several ATM targets in the ATM-p53 axis of the DNA damage response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16943424      PMCID: PMC1592859          DOI: 10.1128/MCB.00562-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  67 in total

1.  Nuclear ataxia-telangiectasia mutated (ATM) mediates the cellular response to DNA double strand breaks in human neuron-like cells.

Authors:  Sharon Biton; Inbal Dar; Leonid Mittelman; Yaron Pereg; Ari Barzilai; Yosef Shiloh
Journal:  J Biol Chem       Date:  2006-04-20       Impact factor: 5.157

2.  14-3-3gamma binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation.

Authors:  Yetao Jin; Mu-Shui Dai; Steven Z Lu; Yingda Xu; Zhijun Luo; Yingming Zhao; Hua Lu
Journal:  EMBO J       Date:  2006-03-02       Impact factor: 11.598

3.  Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3.

Authors:  Cynthia LeBron; Lihong Chen; Daniele M Gilkes; Jiandong Chen
Journal:  EMBO J       Date:  2006-03-02       Impact factor: 11.598

Review 4.  Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4.

Authors:  J-C Marine; S Francoz; M Maetens; G Wahl; F Toledo; G Lozano
Journal:  Cell Death Differ       Date:  2006-06       Impact factor: 15.828

5.  Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding.

Authors:  P R Graves; C M Lovly; G L Uy; H Piwnica-Worms
Journal:  Oncogene       Date:  2001-04-05       Impact factor: 9.867

6.  Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro.

Authors:  S Matsuoka; G Rotman; A Ogawa; Y Shiloh; K Tamai; S J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

7.  Phosphatidylinositol 3-kinase signaling inhibits DAF-16 DNA binding and function via 14-3-3-dependent and 14-3-3-independent pathways.

Authors:  C M Cahill; G Tzivion; N Nasrin; S Ogg; J Dore; G Ruvkun; M Alexander-Bridges
Journal:  J Biol Chem       Date:  2000-12-20       Impact factor: 5.157

8.  A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network.

Authors:  Franck Toledo; Kurt A Krummel; Crystal J Lee; Chung-Wen Liu; Luo-Wei Rodewald; Mengjia Tang; Geoffrey M Wahl
Journal:  Cancer Cell       Date:  2006-04       Impact factor: 31.743

Review 9.  Mammalian cell cycle checkpoints: signalling pathways and their organization in space and time.

Authors:  Jiri Lukas; Claudia Lukas; Jiri Bartek
Journal:  DNA Repair (Amst)       Date:  2004 Aug-Sep

10.  Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo.

Authors:  Sarah Francoz; Pascal Froment; Sven Bogaerts; Sarah De Clercq; Marion Maetens; Gilles Doumont; Eric Bellefroid; Jean-Christophe Marine
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

View more
  42 in total

Review 1.  The p53 orchestra: Mdm2 and Mdmx set the tone.

Authors:  Mark Wade; Yunyuan V Wang; Geoffrey M Wahl
Journal:  Trends Cell Biol       Date:  2010-02-19       Impact factor: 20.808

2.  Regulation of MDMX expression by mitogenic signaling.

Authors:  Daniele M Gilkes; Yu Pan; Domenico Coppola; Timothy Yeatman; Gary W Reuther; Jiandong Chen
Journal:  Mol Cell Biol       Date:  2008-01-02       Impact factor: 4.272

3.  Investigation of non-linear adaptive responses and split dose recovery induced by ionizing radiation in three human epithelial derived cell lines.

Authors:  Lorna A Ryan; Colin B Seymour; Carmel E Mothersill
Journal:  Dose Response       Date:  2009-08-06       Impact factor: 2.658

Review 4.  The regulation of the p53-mediated stress response by MDM2 and MDM4.

Authors:  Mary Ellen Perry
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-01       Impact factor: 10.005

Review 5.  The DNA damage response pathway in normal hematopoiesis and malignancies.

Authors:  Domenico Delia; Shuki Mizutani
Journal:  Int J Hematol       Date:  2017-07-13       Impact factor: 2.490

6.  Mechanism of p53 stabilization by ATM after DNA damage.

Authors:  Qian Cheng; Jiandong Chen
Journal:  Cell Cycle       Date:  2010-02-01       Impact factor: 4.534

7.  Acute toxicity of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) in male Sprague-Dawley rats: effects on hepatic oxidative stress, glutathione and metals status.

Authors:  Ian Lai; Yingtao Chai; Don Simmons; Gregor Luthe; Mitchell C Coleman; Douglas Spitz; Wanda M Haschek; Gabriele Ludewig; Larry W Robertson
Journal:  Environ Int       Date:  2009-12-06       Impact factor: 9.621

8.  Controlling the Mdm2-Mdmx-p53 Circuit.

Authors:  David L Waning; Jason A Lehman; Christopher N Batuello; Lindsey D Mayo
Journal:  Pharmaceuticals (Basel)       Date:  2010-05-18

9.  Protecting the genome from mdm2 and mdmx.

Authors:  Alexia N Melo; Christine M Eischen
Journal:  Genes Cancer       Date:  2012-03

10.  MDM4 (MDMX) and its Transcript Variants.

Authors:  F Mancini; G Di Conza; F Moretti
Journal:  Curr Genomics       Date:  2009-03       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.